Nifty
Sensex
:
:
23151.10
74563.92
-488.05 (-2.06%)
-1470.50 (-1.93%)

Pharmaceuticals & Drugs - Domestic

Rating :
61/99

BSE: 509079 | NSE: GUFICBIO

287.45
13-Mar-2026
  • Open
  • High
  • Low
  • Previous Close
  •  288.1
  •  294
  •  279.05
  •  287.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  47955
  •  13681359.55
  •  407.85
  •  268

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,881.12
  • 57.58
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,139.47
  • 0.03%
  • 4.48

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.50%
  • 2.18%
  • 14.13%
  • FII
  • DII
  • Others
  • 0.44%
  • 3.53%
  • 7.22%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.03
  • 10.95
  • 5.88

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.35
  • 10.20
  • 0.26

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 25.32
  • 9.59
  • -4.27

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 51.00
  • 51.00
  • 51.00

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.97
  • 4.97
  • 4.97

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.46
  • 22.46
  • 22.46

Earnings Forecasts:

(Updated: 14-03-2026)
Description
2024
2025
2026
2027
Adj EPS
6.95
P/E Ratio
41.36
Revenue
819.81
EBITDA
134.69
Net Income
69.65
ROA
6.16
P/B Ratio
4.80
ROE
12.29
FCFF
31.86
FCFF Yield
0.99
Net Debt
320.47
BVPS
59.94

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
231.41
207.79
11.37%
237.05
204.18
16.10%
223.72
202.81
10.31%
205.02
194.99
5.14%
Expenses
198.43
173.87
14.13%
199.21
165.56
20.32%
190.42
167.03
14.00%
178.65
160.77
11.12%
EBITDA
32.98
33.92
-2.77%
37.84
38.62
-2.02%
33.30
35.78
-6.93%
26.37
34.23
-22.96%
EBIDTM
14.25%
16.33%
15.96%
18.91%
14.89%
17.64%
12.86%
17.55%
Other Income
0.79
1.86
-57.53%
2.12
0.11
1,827.27%
0.93
1.26
-26.19%
0.39
0.88
-55.68%
Interest
8.36
4.91
70.26%
9.58
5.18
84.94%
9.23
4.62
99.78%
8.40
3.65
130.14%
Depreciation
7.69
4.62
66.45%
7.77
4.30
80.70%
7.72
4.30
79.53%
7.84
4.34
80.65%
PBT
17.72
26.26
-32.52%
22.60
29.25
-22.74%
17.27
28.11
-38.56%
10.53
27.12
-61.17%
Tax
5.30
6.96
-23.85%
5.78
7.48
-22.73%
4.20
7.25
-42.07%
2.81
7.07
-60.25%
PAT
12.42
19.31
-35.68%
16.82
21.77
-22.74%
13.07
20.86
-37.34%
7.72
20.05
-61.50%
PATM
5.37%
9.29%
7.10%
10.66%
5.84%
10.28%
3.77%
10.28%
EPS
1.24
1.93
-35.75%
1.68
2.17
-22.58%
1.30
2.08
-37.50%
0.77
2.00
-61.50%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Net Sales
897.20
819.81
806.67
Net Sales Growth
10.80%
1.63%
 
Cost Of Goods Sold
395.89
309.97
339.06
Gross Profit
501.31
509.84
467.60
GP Margin
55.87%
62.19%
57.97%
Total Expenditure
766.71
683.71
659.37
Power & Fuel Cost
-
18.46
17.61
% Of Sales
-
2.25%
2.18%
Employee Cost
-
127.19
109.67
% Of Sales
-
15.51%
13.60%
Manufacturing Exp.
-
106.44
89.75
% Of Sales
-
12.98%
11.13%
General & Admin Exp.
-
62.06
54.18
% Of Sales
-
7.57%
6.72%
Selling & Distn. Exp.
-
47.57
40.20
% Of Sales
-
5.80%
4.98%
Miscellaneous Exp.
-
12.04
8.89
% Of Sales
-
1.47%
1.10%
EBITDA
130.49
136.10
147.30
EBITDA Margin
14.54%
16.60%
18.26%
Other Income
4.23
3.63
2.18
Interest
35.57
24.52
16.79
Depreciation
31.02
21.06
17.02
PBT
68.12
94.14
115.67
Tax
18.09
24.49
29.54
Tax Rate
26.56%
26.01%
25.54%
PAT
50.03
69.65
86.14
PAT before Minority Interest
50.03
69.65
86.14
Minority Interest
0.00
0.00
0.00
PAT Margin
5.58%
8.50%
10.68%
PAT Growth
-38.98%
-19.14%
 
EPS
4.99
6.94
8.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Shareholder's Funds
601.08
532.56
Share Capital
10.03
10.03
Total Reserves
590.94
522.53
Non-Current Liabilities
180.73
187.93
Secured Loans
130.50
153.96
Unsecured Loans
0.00
0.00
Long Term Provisions
17.49
15.38
Current Liabilities
387.56
372.05
Trade Payables
158.75
166.27
Other Current Liabilities
70.14
56.48
Short Term Borrowings
154.27
142.02
Short Term Provisions
4.40
7.28
Total Liabilities
1,169.37
1,092.54
Net Block
505.99
158.89
Gross Block
614.12
246.23
Accumulated Depreciation
108.13
87.34
Non Current Assets
544.84
492.06
Capital Work in Progress
21.82
307.06
Non Current Investment
1.78
1.78
Long Term Loans & Adv.
13.18
23.12
Other Non Current Assets
2.06
1.21
Current Assets
624.52
600.48
Current Investments
0.00
0.00
Inventories
216.87
200.48
Sundry Debtors
314.61
329.94
Cash & Bank
29.02
13.48
Other Current Assets
64.02
3.75
Short Term Loans & Adv.
62.52
52.83
Net Current Assets
236.97
228.43
Total Assets
1,169.36
1,092.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Cash From Operating Activity
122.57
-7.46
PBT
94.14
115.67
Adjustment
43.79
34.15
Changes in Working Capital
7.44
-130.23
Cash after chg. in Working capital
145.38
19.59
Interest Paid
0.00
0.00
Tax Paid
-22.81
-27.04
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
-70.78
-102.39
Net Fixed Assets
-82.65
Net Investments
-1.02
Others
12.89
Cash from Financing Activity
-37.20
82.38
Net Cash Inflow / Outflow
14.59
-27.46
Opening Cash & Equivalents
1.14
28.60
Closing Cash & Equivalent
15.72
1.14

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Book Value (Rs.)
59.93
53.11
ROA
6.16%
7.88%
ROE
12.29%
16.17%
ROCE
13.48%
15.59%
Fixed Asset Turnover
2.56
3.82
Receivable days
106.89
128.09
Inventory Days
69.22
77.83
Payable days
191.37
178.99
Cash Conversion Cycle
-15.25
26.94
Total Debt/Equity
0.52
0.60
Interest Cover
4.84
7.89

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.